1,2-dimethylhydrazine decreases expression ISO RGD:1551018 6480464 1, 2-Dimethylhydrazine results in decreased expression of NUAK2 mRNA CTD PMID:22206623 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1551018 6480464 Tetrachlorodibenzodioxin results in decreased expression of NUAK2 mRNA CTD PMID:19933214 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NUAK2 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1551018 6480464 [TIPARP gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of NUAK2 mRNA CTD PMID:25975270 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1551018 6480464 Tetrachlorodibenzodioxin affects the expression of NUAK2 mRNA CTD PMID:21570461 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NUAK2 mRNA CTD PMID:21215274 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of NUAK2 protein CTD PMID:34915118 4,4'-sulfonyldiphenol decreases expression ISO RGD:1551018 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of NUAK2 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases methylation ISO RGD:1551018 6480464 bis(4-hydroxyphenyl)sulfone results in decreased methylation of NUAK2 exon CTD PMID:33297965 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2, 6-dinitrotoluene affects the expression of NUAK2 mRNA CTD PMID:21346803 acrylamide increases expression EXP 6480464 Acrylamide results in increased expression of NUAK2 mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation ISO RGD:1603952 6480464 Aflatoxin B1 results in decreased methylation of NUAK2 gene CTD PMID:27153756 aflatoxin B1 increases expression ISO RGD:1603952 6480464 Aflatoxin B1 results in increased expression of NUAK2 mRNA CTD PMID:21641981 , PMID:27153756 antirheumatic drug decreases expression ISO RGD:1603952 6480464 Antirheumatic Agents results in decreased expression of NUAK2 mRNA CTD PMID:24449571 aristolochic acid increases expression ISO RGD:1603952 6480464 aristolochic acid I results in increased expression of NUAK2 mRNA CTD PMID:33212167 arsane affects expression ISO RGD:1603952 6480464 Arsenic affects the expression of NUAK2 mRNA CTD PMID:18414638 arsane affects methylation ISO RGD:1603952 6480464 Arsenic affects the methylation of NUAK2 gene CTD PMID:25304211 arsenic atom affects expression ISO RGD:1603952 6480464 Arsenic affects the expression of NUAK2 mRNA CTD PMID:18414638 arsenic atom affects methylation ISO RGD:1603952 6480464 Arsenic affects the methylation of NUAK2 gene CTD PMID:25304211 arsenous acid increases expression ISO RGD:1603952 6480464 Arsenic Trioxide results in increased expression of NUAK2 mRNA CTD PMID:20458559 benzo[a]pyrene increases expression ISO RGD:1603952 6480464 Benzo(a)pyrene results in increased expression of NUAK2 mRNA CTD PMID:32234424 Benzo[ghi]perylene increases expression ISO RGD:1551018 6480464 1, 12-benzoperylene results in increased expression of NUAK2 mRNA CTD PMID:26377693 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of NUAK2 mRNA CTD PMID:18164116 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NUAK2 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO RGD:1603952 6480464 bisphenol A results in decreased expression of NUAK2 mRNA CTD PMID:29275510 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NUAK2 gene CTD PMID:28505145 bisphenol A decreases expression ISO RGD:1551018 6480464 bisphenol A results in decreased expression of NUAK2 mRNA CTD PMID:25594700 carbamazepine affects expression ISO RGD:1603952 6480464 Carbamazepine affects the expression of NUAK2 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO RGD:1551018 6480464 Nanotubes, Carbon analog results in increased expression of NUAK2 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO RGD:1603952 6480464 CGP 52608 promotes the reaction [RORA protein binds to NUAK2 gene] CTD PMID:28238834 ciguatoxin CTX1B affects expression ISO RGD:1551018 6480464 Ciguatoxins affects the expression of NUAK2 mRNA CTD PMID:18353800 cisplatin multiple interactions ISO RGD:1603952 6480464 Cisplatin promotes the reaction [jinfukang results in decreased expression of NUAK2 mRNA], jinfukang promotes the reaction [Cisplatin results in decreased expression of NUAK2 mRNA] CTD PMID:27392435 copper(II) sulfate increases expression ISO RGD:1603952 6480464 Copper Sulfate results in increased expression of NUAK2 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1603952 6480464 Asbestos, Crocidolite results in increased expression of NUAK2 mRNA CTD PMID:18687144 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of NUAK2 mRNA CTD PMID:26577399 , PMID:27523638 cyclosporin A increases expression ISO RGD:1603952 6480464 Cyclosporine results in increased expression of NUAK2 mRNA CTD PMID:25562108 cyclosporin A decreases expression ISO RGD:1603952 6480464 Cyclosporine results in decreased expression of NUAK2 mRNA CTD PMID:27989131 diarsenic trioxide increases expression ISO RGD:1603952 6480464 Arsenic Trioxide results in increased expression of NUAK2 mRNA CTD PMID:20458559 diazinon affects expression EXP 6480464 Diazinon affects the expression of NUAK2 mRNA CTD PMID:22546817 dibenz[a,h]anthracene increases expression ISO RGD:1551018 6480464 1 more ... CTD PMID:26377693 dichloroacetic acid decreases expression ISO RGD:1551018 6480464 Dichloroacetic Acid results in decreased expression of NUAK2 mRNA CTD PMID:28962523 fenamidone increases expression ISO RGD:1551018 6480464 fenamidone results in increased expression of NUAK2 mRNA CTD PMID:27029645 fenthion decreases expression ISO RGD:1551018 6480464 Fenthion results in decreased expression of NUAK2 mRNA CTD PMID:34813904 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of NUAK2 mRNA CTD PMID:24136188 folic acid multiple interactions ISO RGD:1603952 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of NUAK2 mRNA CTD PMID:24657277 folic acid decreases expression ISO RGD:1551018 6480464 Folic Acid results in decreased expression of NUAK2 mRNA CTD PMID:25629700 formaldehyde decreases expression ISO RGD:1603952 6480464 Formaldehyde results in decreased expression of NUAK2 mRNA CTD PMID:20655997 graphite affects expression EXP 6480464 Graphite affects the expression of NUAK2 mRNA CTD PMID:29933104 indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA CTD PMID:22129741 lead diacetate increases expression ISO RGD:1551018 6480464 lead acetate results in increased expression of NUAK2 mRNA CTD PMID:21829687 leflunomide increases expression ISO RGD:1603952 6480464 leflunomide results in increased expression of NUAK2 mRNA CTD PMID:28988120 methotrexate decreases expression ISO RGD:1603952 6480464 Methotrexate results in decreased expression of NUAK2 mRNA CTD PMID:24449571 methotrexate multiple interactions ISO RGD:1603952 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in increased expression of NUAK2 mRNA CTD PMID:24657277 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of NUAK2 gene CTD PMID:33148267 N-acetyl-L-cysteine multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA CTD PMID:22129741 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in decreased expression of NUAK2 mRNA, [indole-3-carbinol co-treated with Diethylnitrosamine co-treated with Acetylcysteine] results in decreased expression of NUAK2 mRNA CTD PMID:18164116 , PMID:22129741 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NUAK2 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of NUAK2 mRNA CTD PMID:25729387 panobinostat decreases expression ISO RGD:1603952 6480464 panobinostat results in decreased expression of NUAK2 mRNA CTD PMID:26272509 paracetamol affects expression ISO RGD:1551018 6480464 Acetaminophen affects the expression of NUAK2 mRNA CTD PMID:17562736 paracetamol increases expression ISO RGD:1603952 6480464 Acetaminophen results in increased expression of NUAK2 mRNA CTD PMID:26690555 perfluorooctane-1-sulfonic acid increases expression ISO RGD:1603952 6480464 perfluorooctane sulfonic acid results in increased expression of NUAK2 mRNA CTD PMID:27153767 permethrin multiple interactions EXP 6480464 [Permethrin co-treated with DEET] results in increased methylation of NUAK2 gene CTD PMID:33148267 pirinixic acid multiple interactions ISO RGD:1551018 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NUAK2 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO RGD:1551018 6480464 pirinixic acid results in decreased expression of NUAK2 mRNA CTD PMID:23811191 poly(vinylpyrrolidone) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA CTD PMID:25194297 potassium chromate decreases expression ISO RGD:1603952 6480464 potassium chromate(VI) results in decreased expression of NUAK2 mRNA CTD PMID:22714537 propiconazole decreases expression ISO RGD:1551018 6480464 propiconazole results in decreased expression of NUAK2 mRNA CTD PMID:21278054 quercitrin decreases expression ISO RGD:1603952 6480464 quercitrin results in decreased expression of NUAK2 mRNA CTD PMID:25193878 Salinomycin decreases expression ISO RGD:1603952 6480464 salinomycin results in decreased expression of NUAK2 mRNA CTD PMID:19682730 silicon dioxide increases expression ISO RGD:1603952 6480464 Silicon Dioxide analog results in increased expression of NUAK2 mRNA CTD PMID:23806026 silver atom increases expression ISO RGD:1603952 6480464 Silver results in increased expression of NUAK2 mRNA CTD PMID:26014281 , PMID:28959546 silver atom multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA CTD PMID:25194297 silver(0) increases expression ISO RGD:1603952 6480464 Silver results in increased expression of NUAK2 mRNA CTD PMID:26014281 , PMID:28959546 silver(0) multiple interactions EXP 6480464 [Silver analog co-treated with Povidone] results in decreased expression of NUAK2 mRNA CTD PMID:25194297 sodium arsenite increases expression ISO RGD:1603952 6480464 sodium arsenite results in increased expression of NUAK2 mRNA CTD PMID:34032870 Soman increases expression EXP 6480464 Soman results in increased expression of NUAK2 mRNA CTD PMID:19281266 succimer multiple interactions ISO RGD:1551018 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of NUAK2 mRNA CTD PMID:26378955 sunitinib increases expression ISO RGD:1603952 6480464 Sunitinib results in increased expression of NUAK2 mRNA CTD PMID:31533062 temozolomide increases expression ISO RGD:1603952 6480464 Temozolomide results in increased expression of NUAK2 mRNA CTD PMID:31758290 testosterone increases expression ISO RGD:1551018 6480464 Testosterone deficiency results in increased expression of NUAK2 mRNA CTD PMID:33848595 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NUAK2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1551018 6480464 titanium dioxide results in increased expression of NUAK2 mRNA CTD PMID:23557971 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of NUAK2 mRNA CTD PMID:25729387 trichloroethene decreases expression ISO RGD:1551018 6480464 Trichloroethylene results in decreased expression of NUAK2 mRNA CTD PMID:25549359 trichostatin A decreases expression ISO RGD:1603952 6480464 trichostatin A results in decreased expression of NUAK2 mRNA CTD PMID:26272509 troglitazone decreases expression ISO RGD:1603952 6480464 troglitazone results in decreased expression of NUAK2 mRNA CTD PMID:19140230 valproic acid increases expression ISO RGD:1551018 6480464 Valproic Acid results in increased expression of NUAK2 mRNA CTD PMID:21427059 valproic acid affects expression ISO RGD:1603952 6480464 Valproic Acid affects the expression of NUAK2 mRNA CTD PMID:25979313 valproic acid decreases expression ISO RGD:1603952 6480464 Valproic Acid results in decreased expression of NUAK2 mRNA CTD PMID:26272509 , PMID:29154799